Market Overview:
The global bulk drug intermediates market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for bulk drug intermediates from the pharmaceutical and biotechnology industries. In addition, the growing demand for generic drugs is also contributing to the growth of this market. The global bulk drug intermediates market can be segmented on the basis of type into GMP and non-GMP products. The GMP segment is expected to account for a larger share of this market than the non-GMP segment during the forecast period. This can be attributed to stringent regulatory requirements governing GMP products, which results in higher quality standards compared with non-GMP products. On the basis of application, antibiotics, antipyretic analgesics, vitamins and others are some ofthe major segments in this market.
Product Definition:
Bulk drug intermediates are chemical compounds that are used in the manufacture of pharmaceuticals. They are not themselves drugs, but they are necessary for the production of pharmaceuticals. The importance of bulk drug intermediates is that they allow manufacturers to produce large quantities of drugs at a low cost.
GMP:
Global GMP is a term used for the maximum level of purity that can be achieved with an industrial process. It is a set standard which has been established by the WHO and International Association for Pharmaceutical Industry (IAPhI) to regulate drug manufacturing processes. The global GMP includes four grades, namely Good Manufacturing Practices (GMP), Good Distribution Practices (GDP), goodagricultural practices(GAP), and reference standards.
Non-GMP:
Non-GMP is short for non-grand mal epilepsy. It is a term used to define seizures that occur in the absence of traumatic brain injury or stroke. Epilepsy can be classified into two types: simple and complex. Simple epilepsy consists of unprovoked seizures, while complex involves a series of provocations leading to an epileptic fit.
Application Insights:
The antibiotics segment dominated the global market in terms of revenue share in 2017. This is attributed to increasing use of these drugs for the treatment of bacterial infections, such as tuberculosis, staphylococcal infections and streptococcal diseases. Moreover, growing demand for antibacterial drugs to treat various chronic diseases is expected to boost product demand over the forecast period.
The antipyretic analgesics segment accounted for a significant share in 2017 owing to rising incidences of fever and pain disorders across the globe. Increasing geriatric population base and cases of trauma are also anticipated to drive this application segment over the forecast period. In addition, stringent regulations regarding consumption and distribution of medicines during heat waves will further propel industry growth during next eight years from 2018 till 2030.
Regional Analysis:
Asia Pacific dominated the global BDIs market in 2017 and is expected to continue its dominance over the forecast period. The presence of emerging economies such as China, India, and Japan has resulted in a high demand for medicines. Furthermore, increasing healthcare spending by governments along with rising awareness regarding chronic diseases are some of the factors that can be attributed to regional growth.
The Asia Pacific region is also home to several pharmaceutical companies that are engaged in drug discovery research activities. These companies focus on generating revenue from multiple sources including product sales, contract research services (CROs), and collaborations with universities & colleges for R&D purposes.
Growth Factors:
- Increasing demand for bulk drug intermediates from the pharmaceutical and biotechnology industries as a result of the growth in these industries.
- The increasing use of bulk drug intermediates in the manufacture of generic drugs, which is expected to drive market growth over the next few years.
- Growing demand for new and improved products that offer better performance, quality, and safety is also expected to fuel market growth over the forecast period.
- Rising investments by manufacturers in research and development activities to develop novel products is also anticipated to boost market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bulk Drug Intermediates Market Research Report
By Type
GMP, Non-GMP
By Application
Antibiotics, Antipyretic Analgesics, Vitamins, Others
By Companies
Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, ABA Chem, Tianma, Jiujiujiu, Alpha, Jiuzhou, Yongtai
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
144
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Bulk Drug Intermediates Market Report Segments:
The global Bulk Drug Intermediates market is segmented on the basis of:
Types
GMP, Non-GMP
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antibiotics, Antipyretic Analgesics, Vitamins, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
Highlights of The Bulk Drug Intermediates Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- GMP
- Non-GMP
- By Application:
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bulk Drug Intermediates Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bulk drug intermediates are chemicals used to produce drugs. They are made from natural or synthetic materials and can be used in the production of prescription and over-the-counter medications.
Some of the major players in the bulk drug intermediates market are Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, ABA Chem, Tianma, Jiujiujiu, Alpha, Jiuzhou, Yongtai.
The bulk drug intermediates market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bulk Drug Intermediates Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bulk Drug Intermediates Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bulk Drug Intermediates Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bulk Drug Intermediates Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bulk Drug Intermediates Market Size & Forecast, 2020-2028
4.5.1 Bulk Drug Intermediates Market Size and Y-o-Y Growth
4.5.2 Bulk Drug Intermediates Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 GMP
5.2.2 Non-GMP
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Antibiotics
6.2.2 Antipyretic Analgesics
6.2.3 Vitamins
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bulk Drug Intermediates Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bulk Drug Intermediates Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 GMP
9.6.2 Non-GMP
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Antibiotics
9.10.2 Antipyretic Analgesics
9.10.3 Vitamins
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 GMP
10.6.2 Non-GMP
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Antibiotics
10.10.2 Antipyretic Analgesics
10.10.3 Vitamins
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 GMP
11.6.2 Non-GMP
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Antibiotics
11.10.2 Antipyretic Analgesics
11.10.3 Vitamins
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 GMP
12.6.2 Non-GMP
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Antibiotics
12.10.2 Antipyretic Analgesics
12.10.3 Vitamins
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 GMP
13.6.2 Non-GMP
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Antibiotics
13.10.2 Antipyretic Analgesics
13.10.3 Vitamins
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bulk Drug Intermediates Market: Competitive Dashboard
14.2 Global Bulk Drug Intermediates Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza
14.3.2 Catalent
14.3.3 Patheon
14.3.4 Jubilant
14.3.5 Granules
14.3.6 Ganesh
14.3.7 Chemcon
14.3.8 BASF
14.3.9 Porton
14.3.10 Lianhetech
14.3.11 ABA Chem
14.3.12 Tianma
14.3.13 Jiujiujiu
14.3.14 Alpha
14.3.15 Jiuzhou
14.3.16 Yongtai
